PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 113 filers reported holding PTC THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,014,153 | -44.9% | 3,168,860 | -0.1% | 0.00% | -42.9% |
| Q2 2023 | $128,943,584 | -8.4% | 3,170,484 | +9.1% | 0.01% | -12.5% |
| Q1 2023 | $140,724,643 | -46.4% | 2,905,133 | -57.8% | 0.01% | 0.0% |
| Q4 2022 | $262,494,402 | +85.2% | 6,876,982 | +143.6% | 0.01% | -11.1% |
| Q3 2022 | $141,726,000 | -2.4% | 2,823,232 | -22.1% | 0.01% | 0.0% |
| Q2 2022 | $145,213,000 | +22.2% | 3,624,877 | +13.8% | 0.01% | +50.0% |
| Q1 2022 | $118,796,000 | +6.5% | 3,184,027 | +13.7% | 0.01% | +20.0% |
| Q4 2021 | $111,581,000 | +13.2% | 2,801,431 | +5.8% | 0.01% | 0.0% |
| Q3 2021 | $98,555,000 | -1.9% | 2,648,621 | +11.4% | 0.01% | 0.0% |
| Q2 2021 | $100,477,000 | +4.4% | 2,377,027 | +17.0% | 0.01% | -16.7% |
| Q1 2021 | $96,208,000 | -27.7% | 2,031,858 | -6.9% | 0.01% | -25.0% |
| Q4 2020 | $133,143,000 | +24.7% | 2,181,597 | -4.5% | 0.01% | +14.3% |
| Q3 2020 | $106,759,000 | -10.0% | 2,283,608 | -2.3% | 0.01% | -22.2% |
| Q2 2020 | $118,568,000 | +12.0% | 2,336,783 | -1.5% | 0.01% | 0.0% |
| Q1 2020 | $105,845,000 | -5.8% | 2,372,677 | +1.4% | 0.01% | +12.5% |
| Q4 2019 | $112,340,000 | +60.1% | 2,338,946 | +12.7% | 0.01% | +60.0% |
| Q3 2019 | $70,173,000 | -32.6% | 2,074,902 | -10.3% | 0.01% | -37.5% |
| Q2 2019 | $104,120,000 | +10.6% | 2,313,768 | -7.5% | 0.01% | +14.3% |
| Q1 2019 | $94,135,000 | +14.4% | 2,500,926 | +4.3% | 0.01% | 0.0% |
| Q4 2018 | $82,310,000 | -23.1% | 2,398,314 | +5.4% | 0.01% | -12.5% |
| Q3 2018 | $106,982,000 | +26.0% | 2,276,178 | -9.6% | 0.01% | +14.3% |
| Q2 2018 | $84,899,000 | +45.2% | 2,516,928 | +16.4% | 0.01% | +40.0% |
| Q1 2018 | $58,489,000 | +28.7% | 2,161,406 | -20.7% | 0.01% | +25.0% |
| Q4 2017 | $45,445,000 | +29.4% | 2,724,315 | +55.2% | 0.00% | +33.3% |
| Q3 2017 | $35,120,000 | +14.1% | 1,755,186 | +4.5% | 0.00% | 0.0% |
| Q2 2017 | $30,784,000 | +64.9% | 1,679,615 | -11.4% | 0.00% | +50.0% |
| Q1 2017 | $18,668,000 | +188.0% | 1,896,674 | +219.1% | 0.00% | +100.0% |
| Q4 2016 | $6,483,000 | -29.8% | 594,396 | -9.9% | 0.00% | 0.0% |
| Q3 2016 | $9,236,000 | +125.8% | 659,346 | +13.2% | 0.00% | – |
| Q2 2016 | $4,091,000 | -2.4% | 582,348 | -10.5% | 0.00% | – |
| Q1 2016 | $4,190,000 | -91.5% | 650,635 | -57.2% | 0.00% | -100.0% |
| Q4 2015 | $49,310,000 | +58.8% | 1,521,909 | +30.9% | 0.01% | +25.0% |
| Q3 2015 | $31,047,000 | -34.1% | 1,162,852 | +18.7% | 0.00% | -20.0% |
| Q2 2015 | $47,133,000 | +11.7% | 979,298 | +41.2% | 0.01% | +25.0% |
| Q1 2015 | $42,198,000 | +17.1% | 693,484 | -0.3% | 0.00% | 0.0% |
| Q4 2014 | $36,030,000 | -0.4% | 695,897 | -15.3% | 0.00% | 0.0% |
| Q3 2014 | $36,168,000 | +63.6% | 821,814 | -2.8% | 0.00% | +100.0% |
| Q2 2014 | $22,113,000 | +22.0% | 845,838 | +22.0% | 0.00% | 0.0% |
| Q1 2014 | $18,129,000 | +860.2% | 693,456 | +523.0% | 0.00% | – |
| Q4 2013 | $1,888,000 | +1.0% | 111,314 | +27.8% | 0.00% | – |
| Q3 2013 | $1,870,000 | – | 87,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |